Literature DB >> 20726825

Association of the brain-derived neurotrophic factor Val66Met polymorphism with hippocampus volumes in drug-free depressed patients.

Ali Saffet Gonul1, Omer Kitis, M Cagdas Eker, Ozlem Donat Eker, Erol Ozan, Kerry Coburn.   

Abstract

OBJECTIVES: Val66Met BDNF gene polymorphism is shown to affect the function of mature BDNF and mature BDNF plays an important role in the hippocampal neurogenesis and neuronal survival.
METHODS: A relationship of Val66Met BDNF gene polymorphism and hippocampal volumes in 33 MDD patients and 40 healthy controls is investigated. Region of interest analysis was conducted on the images acquired via MRI.
RESULTS: Depressed patients had smaller left hippocampal volumes compared to healthy controls. The diagnosis of MDD was not significantly related to hippocampal volumes among Met carriers; however, among Val homozygotes depressed patients had significantly smaller left hippocampal volumes compared to controls. Although both right and left hippocampal volumes showed nearly significant correlation with the duration of illness, this correlation reached (negative) significant levels only in the right hippocampal volume of the Val homozygotes.
CONCLUSIONS: Val homozygote genotype may serve as a vulnerability factor in MDD regarding hippocampal volume loss. This finding can be considered as a supportive evidence for the neurotrophic factor hypothesis of depression.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20726825     DOI: 10.3109/15622975.2010.507786

Source DB:  PubMed          Journal:  World J Biol Psychiatry        ISSN: 1562-2975            Impact factor:   4.132


  20 in total

1.  Reduced hippocampal volumes in healthy carriers of brain-derived neurotrophic factor Val66Met polymorphism: meta-analysis.

Authors:  Tomas Hajek; Miloslav Kopecek; Cyril Höschl
Journal:  World J Biol Psychiatry       Date:  2011-07-04       Impact factor: 4.132

Review 2.  Neuroimaging genomic studies in major depressive disorder: A systematic review.

Authors:  Hui-Feng Zhang; David Mellor; Dai-Hui Peng
Journal:  CNS Neurosci Ther       Date:  2018-02-23       Impact factor: 5.243

3.  The antidepressant efficacy of subanesthetic-dose ketamine does not correlate with baseline subcortical volumes in a replication sample with major depressive disorder.

Authors:  Mark J Niciu; Nicolas D Iadarola; Dipavo Banerjee; David A Luckenbaugh; Minkyung Park; Marc Lener; Lawrence Park; Dawn F Ionescu; Elizabeth D Ballard; Nancy E Brutsche; Nirmala Akula; Francis J McMahon; Rodrigo Machado-Vieira; Allison C Nugent; Carlos A Zarate
Journal:  J Psychopharmacol       Date:  2017-10-17       Impact factor: 4.153

4.  BDNF Val66Met genotype interacts with childhood adversity and influences the formation of hippocampal subfields.

Authors:  Thomas Frodl; Norbert Skokauskas; Eva-Maria Frey; Derek Morris; Michael Gill; Angela Carballedo
Journal:  Hum Brain Mapp       Date:  2014-07-10       Impact factor: 5.038

Review 5.  Serum BDNF concentrations as peripheral manifestations of depression: evidence from a systematic review and meta-analyses on 179 associations (N=9484).

Authors:  M L Molendijk; P Spinhoven; M Polak; B A A Bus; B W J H Penninx; B M Elzinga
Journal:  Mol Psychiatry       Date:  2013-08-20       Impact factor: 15.992

Review 6.  Fear conditioning, synaptic plasticity and the amygdala: implications for posttraumatic stress disorder.

Authors:  Amy L Mahan; Kerry J Ressler
Journal:  Trends Neurosci       Date:  2011-07-26       Impact factor: 13.837

Review 7.  The aging hippocampus: interactions between exercise, depression, and BDNF.

Authors:  Kirk I Erickson; Destiny L Miller; Kathryn A Roecklein
Journal:  Neuroscientist       Date:  2011-04-29       Impact factor: 7.519

8.  No effect of 5HTTLPR or BDNF Val66Met polymorphism on hippocampal morphology in major depression.

Authors:  J Cole; D R Weinberger; V S Mattay; X Cheng; A W Toga; P M Thompson; G Powell-Smith; S Cohen-Woods; A Simmons; P McGuffin; C H Y Fu
Journal:  Genes Brain Behav       Date:  2011-07-12       Impact factor: 3.449

9.  Effect of the BDNF Val66Met polymorphism on regional gray matter volumes and cognitive function in the Chinese population.

Authors:  Mu-En Liu; Chu-Chung Huang; Mu-Hong Chen; Albert C Yang; Pei-Chi Tu; Heng-Liang Yeh; Chen-Jee Hong; Jin-Fan Chen; Jen-Ping Hwang; Ching-Po Lin; Shih-Jen Tsai
Journal:  Neuromolecular Med       Date:  2013-12-24       Impact factor: 3.843

10.  No influence of brain-derived neurotrophic factor (BDNF) polymorphisms on treatment response in a naturalistic sample of patients with major depression.

Authors:  Richard Musil; Peter Zill; Florian Seemüller; Brigitta Bondy; Michael Obermeier; Ilja Spellmann; Wolfram Bender; Mazda Adli; Isabella Heuser; Joachim Zeiler; Wolfgang Gaebel; Wolfgang Maier; Marcella Rietschel; Dan Rujescu; Rebecca Schennach; Hans-Jürgen Möller; Michael Riedel
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-09-11       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.